(Q54461977)

30 May 2018

title

Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension. (English)

1 reference

30 May 2018

main subject

arterial hypertension

0 references

1 reference

1 reference

R A Sánchez

1

1 reference

30 May 2018

E Marcó

2

1 reference

30 May 2018

H B Gilbert

3

1 reference

30 May 2018

P Raffaele

4

1 reference

30 May 2018

M Brito

5

1 reference

30 May 2018

M Giménez

6

1 reference

30 May 2018

L I Moledo

7

1 reference

30 May 2018

publication date

1 January 1985

1 reference

30 May 2018

published in

Drugs

1 reference

30 May 2018

volume

30 Suppl 1

1 reference

30 May 2018

page(s)

49-58

1 reference

30 May 2018

Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade

cites work

1 reference

12 December 2020

The angiotensin converting enzyme inhibitor enalapril and its effects on renal function

1 reference

12 December 2020

Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?

1 reference

12 December 2020

Time Course and Effect of Sodium Intake on Vascular and Hormonal Responses to Enalapril (MK 421) in Normal Subjects

1 reference

12 December 2020

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

1 reference

12 December 2020

Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone

1 reference

12 December 2020

THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY

1 reference

12 December 2020

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

12 December 2020

Role of the intrarenal renin-angiotensin system in the control of renal function

1 reference

12 December 2020

Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure

1 reference

12 December 2020

The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis

1 reference

12 December 2020

Endocrine profile in the long-term phase of converting-enzyme inhibition

1 reference

12 December 2020

Clinical use of an orally acting converting enzyme inhibitor: captopril

1 reference

12 December 2020

Sustained haemodynamic effects of enalapril in left ventricular failure

1 reference

12 December 2020

Sodium intake and renal responses to captopril in normal man and in essential hypertension

1 reference

12 December 2020

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

12 December 2020

Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure

1 reference

12 December 2020

Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential Hypertension

1 reference

12 December 2020

Physiological effects of short-term treatment with enalapril in hypertensive patients

1 reference

12 December 2020

Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture

1 reference

12 December 2020

Enalapril (MK421) in the treatment of hypertension with renal artery stenosis

1 reference

12 December 2020

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis

1 reference

12 December 2020

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

12 December 2020

Captopril lowers urinary kallikrein in hypertensive patients

1 reference

12 December 2020

Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition

1 reference

12 December 2020

Control of aldosterone secretion

1 reference

12 December 2020

Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure

1 reference

12 December 2020

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

12 December 2020

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"

1 reference

12 December 2020

Intrarenal control of electrolyte excretion by angiotensin II

1 reference

12 December 2020

Direct measurement of papillary collecting duct sodium transport in the rat. Evidence for heterogeneity of nephron function during Ringer loading

1 reference

12 December 2020

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

12 December 2020

Treatment of hypertension with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Methods for Determination of Prekallikrein in Plasma, Glandular Kallikrein and Urokinase

1 reference

12 December 2020

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

12 December 2020

Converting enzyme inhibition and the kidney

1 reference

12 December 2020

Intrarenal role of angiotensin II and [des-Asp1]angiotensin II

1 reference

12 December 2020

Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition

1 reference

12 December 2020

Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension

1 reference

12 December 2020

Rise of plasma aldosterone during long-term captopril treatment

1 reference

12 December 2020

Total exchangeable sodium in essential hypertension and hypertension with chronic renal insufficiency

1 reference

12 December 2020

Captopril, angiotensin II, and sodium in blood-pressure regulation

1 reference

12 December 2020

Endocrine and Cardiovascular Influences of Converting Enzyme Inhibition with SQ 14225 in Hypertensive Patients in the Supine Position and during Head-Up Tilt before and after Sodium Depletion*

1 reference

12 December 2020

Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure

1 reference

12 December 2020

Long-term clinical experience with enalapril in essential hypertension

1 reference

12 December 2020

Measurement of renal clearance of inulin and PAH in the steady state without urine collection

1 reference

12 December 2020

Captopril in the treatment of clinical hypertension and cardiac failure

1 reference

12 December 2020

Effect of Angiotensin Converting Enzyme Inhibition on Blood Pressure, Plasma Renin Activity and Plasma Aldosterone in Essential Hypertension *

1 reference

12 December 2020

Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects

1 reference

12 December 2020

Plasma renin activity in essential hypertension

1 reference

12 December 2020

Identifiers

PubMed ID

2994987

1 reference

30 May 2018